Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Preliminary Results of a Prospective Observational Study to Assess the Prevalence of Gaucher Disease in an Adult Population Affected By MGUS

Gaetano Giuffrida, MD, Concetta Conticello, MD, Daniela Nicolosi, PharmD, Valeria Calafiore, Alessandra Romano, MD PhD, Ugo Consoli, MD, Caterina Musolino, MD, Vanessa Innao, Flavia Fiorenza, MD, Cinzia Maugeri, MD, Giuseppe Longo, MD, Maria Rocca Cingari, MD, Francesco Di Raimondo, MD

Blood (2019) 134 (Supplement_1): 4868.

https://doi.org/10.1182/blood-2019-129944

Published: 2019

Journal Articles

Beta-Thalassemia (BT) Prevalence and Treatment Patterns in Italy: A Survey of Treating Physicians

Emanuele Angelucci, MD, Nigel Burrows, Stefano Losi, Chris Bartiromo, X. Henry Hu, MD PhD

Blood (2016) 128 (22): 3533.

https://doi.org/10.1182/blood.V128.22.3533.3533

Published: 2016

Journal Articles

Patients with Sickle Cell Disease in Sicily Have Lower Rates of End Organ Damage, Allo-Immunization and Opioid Prescription Compared to a US Cohort

Caterina Minniti, MD, Concetta Perrotta, Di Raimondo Francesco, Alessandra Quota, James G. Taylor, MD

Blood (2016) 128 (22): 3664.

https://doi.org/10.1182/blood.V128.22.3664.3664

Published: 2016

Journal Articles

BCR-ABL IS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy.

Paolo Vigneri, MD, PhD, Fabio Stagno, MD, Stefania Stella, PhD, Alessandra Cupri, MD, PhD, Michele Massimino, PhD, Agostino Antolino, MD, Vincenzo Abbadessa, MD, Maura Brugiatelli, MD, Patrizia Guglielmo, MD, Caterina Musolino, MD, Diamante Turri, MD, Mario Russo, MD, Guido Pagnucco, MD, Michele Rizzo, MD, Maurizio Musso, MD, Fortunato Morabito, MD, Luciano Levato, Angelo Messina, MD, Francesco Di Raimondo, MD

Blood (2010) 116 (21): 3426.

https://doi.org/10.1182/blood.V116.21.3426.3426

Published: 2010

Journal Articles

Sustained Responses and Resistance to Imatinib Mesylate in the First 173 Chronic Myeloid Leukemia Patients Accrued by the SCREEN Multicenter Study: First Interim Report.

Blood (2009) 114 (22): 4276.

https://doi.org/10.1182/blood.V114.22.4276.4276

Published: 2009

Journal Articles

The Spectrum of δ-Thalassemia in the Western Sicily.

Aurelio Maggio, MD, Cristina Passarello, PhD, Gaetano Ruggeri, MD, Pietro Teresi, MD, Maurizio Anzà, MD, Anna Meo, MD, Antonino Giambona, PhD

Blood (2005) 106 (11): 3824.

https://doi.org/10.1182/blood.V106.11.3824.3824

Published: 2005

Journal Articles

Treatment with Hydroxyurea in Sickle Cell/ ß Thalassemia: A Long-Term Experience.

Aurelio Maggio, MD, Paolo Rigano, MD, Disma Renda, MD

Blood (2004) 104 (11): 1678.

https://doi.org/10.1182/blood.V104.11.1678.1678

Published: 2004

Journal Articles

New Data on Microdrepanocytic Disease

E. SILVESTRONI, I. BIANCO

Blood (1955) 10 (6): 623–632.

https://doi.org/10.1182/blood.V10.6.623.623

Published: 1955

NARROW

Preliminary Results of a Prospective Observational Study to Assess the Prevalence of Gaucher Disease in an Adult Population Affected By MGUS

Beta-Thalassemia (BT) Prevalence and Treatment Patterns in Italy: A Survey of Treating Physicians

Patients with Sickle Cell Disease in Sicily Have Lower Rates of End Organ Damage, Allo-Immunization and Opioid Prescription Compared to a US Cohort

BCR-ABL IS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy.

Sustained Responses and Resistance to Imatinib Mesylate in the First 173 Chronic Myeloid Leukemia Patients Accrued by the SCREEN Multicenter Study: First Interim Report.

The Spectrum of δ-Thalassemia in the Western Sicily.

Treatment with Hydroxyurea in Sickle Cell/ ß Thalassemia: A Long-Term Experience.

New Data on Microdrepanocytic Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only